nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLCO1A2—Chlorambucil—testicular cancer	0.209	0.25	CbGbCtD
Levothyroxine—SLCO4C1—Methotrexate—testicular cancer	0.155	0.185	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—testicular cancer	0.109	0.13	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—testicular cancer	0.0606	0.0726	CbGbCtD
Levothyroxine—CYP2C8—Ifosfamide—testicular cancer	0.0473	0.0567	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—testicular cancer	0.0374	0.0448	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—testicular cancer	0.0353	0.0423	CbGbCtD
Levothyroxine—ABCB1—Dactinomycin—testicular cancer	0.0271	0.0325	CbGbCtD
Levothyroxine—CYP2C8—Etoposide—testicular cancer	0.0226	0.0271	CbGbCtD
Levothyroxine—ALB—Methotrexate—testicular cancer	0.0193	0.0232	CbGbCtD
Levothyroxine—CYP3A4—Ifosfamide—testicular cancer	0.0192	0.023	CbGbCtD
Levothyroxine—ABCB1—Vinblastine—testicular cancer	0.017	0.0203	CbGbCtD
Levothyroxine—ABCB1—Cisplatin—testicular cancer	0.0156	0.0187	CbGbCtD
Levothyroxine—ABCB1—Etoposide—testicular cancer	0.0153	0.0183	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—testicular cancer	0.0104	0.0125	CbGbCtD
Levothyroxine—CYP3A4—Vinblastine—testicular cancer	0.0102	0.0122	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—testicular cancer	0.0101	0.0121	CbGbCtD
Levothyroxine—CYP3A4—Etoposide—testicular cancer	0.00917	0.011	CbGbCtD
Levothyroxine—CYP3A4—Doxorubicin—testicular cancer	0.00626	0.00749	CbGbCtD
Levothyroxine—SLCO4C1—seminal vesicle—testicular cancer	0.00403	0.0746	CbGeAlD
Levothyroxine—TTR—embryo—testicular cancer	0.00306	0.0566	CbGeAlD
Levothyroxine—SLC7A5—seminal vesicle—testicular cancer	0.00295	0.0546	CbGeAlD
Levothyroxine—THRA—gonad—testicular cancer	0.00279	0.0517	CbGeAlD
Levothyroxine—THRB—gonad—testicular cancer	0.00279	0.0517	CbGeAlD
Levothyroxine—SLCO4A1—seminal vesicle—testicular cancer	0.00257	0.0477	CbGeAlD
Levothyroxine—THRA—female gonad—testicular cancer	0.00227	0.042	CbGeAlD
Levothyroxine—THRB—female gonad—testicular cancer	0.00227	0.042	CbGeAlD
Levothyroxine—SLC7A5—gonad—testicular cancer	0.00213	0.0395	CbGeAlD
Levothyroxine—SLC16A2—female gonad—testicular cancer	0.00205	0.0381	CbGeAlD
Levothyroxine—THRB—testis—testicular cancer	0.00201	0.0373	CbGeAlD
Levothyroxine—THRA—testis—testicular cancer	0.00201	0.0373	CbGeAlD
Levothyroxine—SLC16A2—testis—testicular cancer	0.00182	0.0338	CbGeAlD
Levothyroxine—SLC7A5—female gonad—testicular cancer	0.00173	0.0321	CbGeAlD
Levothyroxine—SLCO1C1—testis—testicular cancer	0.00167	0.031	CbGeAlD
Levothyroxine—SLC7A5—testis—testicular cancer	0.00153	0.0284	CbGeAlD
Levothyroxine—TTR—testis—testicular cancer	0.00149	0.0277	CbGeAlD
Levothyroxine—THRB—lymph node—testicular cancer	0.00146	0.027	CbGeAlD
Levothyroxine—THRA—lymph node—testicular cancer	0.00146	0.027	CbGeAlD
Levothyroxine—SLCO4A1—testis—testicular cancer	0.00134	0.0248	CbGeAlD
Levothyroxine—SLC16A2—lymph node—testicular cancer	0.00132	0.0245	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—testicular cancer	0.00121	0.0225	CbGeAlD
Levothyroxine—SLC7A5—lymph node—testicular cancer	0.00111	0.0206	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—testicular cancer	0.000971	0.018	CbGeAlD
Levothyroxine—SLCO1A2—testis—testicular cancer	0.00096	0.0178	CbGeAlD
Levothyroxine—ALB—testis—testicular cancer	0.000954	0.0177	CbGeAlD
Levothyroxine—Acute coronary syndrome—Bleomycin—testicular cancer	0.000775	0.00698	CcSEcCtD
Levothyroxine—Myocardial infarction—Bleomycin—testicular cancer	0.00077	0.00694	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Etoposide—testicular cancer	0.000759	0.00684	CcSEcCtD
Levothyroxine—Tremor—Chlorambucil—testicular cancer	0.000743	0.0067	CcSEcCtD
Levothyroxine—Alopecia—Vinblastine—testicular cancer	0.000738	0.00665	CcSEcCtD
Levothyroxine—Angina pectoris—Ifosfamide—testicular cancer	0.000734	0.00661	CcSEcCtD
Levothyroxine—Agitation—Chlorambucil—testicular cancer	0.000729	0.00657	CcSEcCtD
Levothyroxine—Angioedema—Chlorambucil—testicular cancer	0.000725	0.00654	CcSEcCtD
Levothyroxine—Irritability—Cisplatin—testicular cancer	0.000717	0.00646	CcSEcCtD
Levothyroxine—Cardiac failure—Etoposide—testicular cancer	0.000705	0.00636	CcSEcCtD
Levothyroxine—Dehydration—Cisplatin—testicular cancer	0.000699	0.0063	CcSEcCtD
Levothyroxine—ALB—lymph node—testicular cancer	0.000692	0.0128	CbGeAlD
Levothyroxine—Convulsion—Chlorambucil—testicular cancer	0.000687	0.0062	CcSEcCtD
Levothyroxine—CYP2C8—testis—testicular cancer	0.00067	0.0124	CbGeAlD
Levothyroxine—Acute coronary syndrome—Ifosfamide—testicular cancer	0.000662	0.00597	CcSEcCtD
Levothyroxine—Myocardial infarction—Ifosfamide—testicular cancer	0.000658	0.00593	CcSEcCtD
Levothyroxine—ABCB1—embryo—testicular cancer	0.000657	0.0122	CbGeAlD
Levothyroxine—Flushing—Bleomycin—testicular cancer	0.000655	0.0059	CcSEcCtD
Levothyroxine—Cardiac arrest—Etoposide—testicular cancer	0.000654	0.0059	CcSEcCtD
Levothyroxine—Confusional state—Chlorambucil—testicular cancer	0.000653	0.00589	CcSEcCtD
Levothyroxine—Sweating increased—Cisplatin—testicular cancer	0.000632	0.0057	CcSEcCtD
Levothyroxine—Convulsion—Vinblastine—testicular cancer	0.00063	0.00568	CcSEcCtD
Levothyroxine—Alopecia—Bleomycin—testicular cancer	0.000623	0.00562	CcSEcCtD
Levothyroxine—ABCB1—seminal vesicle—testicular cancer	0.000617	0.0114	CbGeAlD
Levothyroxine—Flushing—Dactinomycin—testicular cancer	0.00061	0.0055	CcSEcCtD
Levothyroxine—Dysphagia—Etoposide—testicular cancer	0.000595	0.00536	CcSEcCtD
Levothyroxine—Alopecia—Dactinomycin—testicular cancer	0.000581	0.00524	CcSEcCtD
Levothyroxine—Sweating increased—Etoposide—testicular cancer	0.000579	0.00522	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Cisplatin—testicular cancer	0.000571	0.00515	CcSEcCtD
Levothyroxine—Myocardial infarction—Cisplatin—testicular cancer	0.000567	0.00512	CcSEcCtD
Levothyroxine—Flushing—Ifosfamide—testicular cancer	0.000559	0.00504	CcSEcCtD
Levothyroxine—Fatigue—Chlorambucil—testicular cancer	0.000558	0.00503	CcSEcCtD
Levothyroxine—Arrhythmia—Ifosfamide—testicular cancer	0.000538	0.00486	CcSEcCtD
Levothyroxine—Feeling abnormal—Chlorambucil—testicular cancer	0.000534	0.00481	CcSEcCtD
Levothyroxine—Alopecia—Ifosfamide—testicular cancer	0.000533	0.0048	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000529	0.00477	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Etoposide—testicular cancer	0.000523	0.00471	CcSEcCtD
Levothyroxine—Myocardial infarction—Etoposide—testicular cancer	0.00052	0.00469	CcSEcCtD
Levothyroxine—Coma—Methotrexate—testicular cancer	0.000519	0.00468	CcSEcCtD
Levothyroxine—Urticaria—Chlorambucil—testicular cancer	0.000514	0.00464	CcSEcCtD
Levothyroxine—Abdominal pain—Chlorambucil—testicular cancer	0.000512	0.00461	CcSEcCtD
Levothyroxine—Body temperature increased—Chlorambucil—testicular cancer	0.000512	0.00461	CcSEcCtD
Levothyroxine—Confusional state—Bleomycin—testicular cancer	0.000505	0.00456	CcSEcCtD
Levothyroxine—Feeling abnormal—Vinblastine—testicular cancer	0.000489	0.00441	CcSEcCtD
Levothyroxine—Coma—Epirubicin—testicular cancer	0.000486	0.00438	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Vinblastine—testicular cancer	0.000485	0.00437	CcSEcCtD
Levothyroxine—Flushing—Cisplatin—testicular cancer	0.000482	0.00435	CcSEcCtD
Levothyroxine—Agitation—Ifosfamide—testicular cancer	0.000482	0.00435	CcSEcCtD
Levothyroxine—Angioedema—Ifosfamide—testicular cancer	0.000479	0.00432	CcSEcCtD
Levothyroxine—Abdominal pain—Vinblastine—testicular cancer	0.000469	0.00423	CcSEcCtD
Levothyroxine—Asthenia—Chlorambucil—testicular cancer	0.000465	0.00419	CcSEcCtD
Levothyroxine—Arrhythmia—Cisplatin—testicular cancer	0.000464	0.00419	CcSEcCtD
Levothyroxine—Palpitations—Ifosfamide—testicular cancer	0.000464	0.00418	CcSEcCtD
Levothyroxine—Alopecia—Cisplatin—testicular cancer	0.000459	0.00414	CcSEcCtD
Levothyroxine—Pruritus—Chlorambucil—testicular cancer	0.000458	0.00413	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000457	0.00412	CcSEcCtD
Levothyroxine—Convulsion—Ifosfamide—testicular cancer	0.000455	0.0041	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—testicular cancer	0.000449	0.00405	CcSEcCtD
Levothyroxine—Dyspnoea—Bleomycin—testicular cancer	0.000447	0.00403	CcSEcCtD
Levothyroxine—Arthralgia—Ifosfamide—testicular cancer	0.000447	0.00403	CcSEcCtD
Levothyroxine—ABCB1—gonad—testicular cancer	0.000446	0.00827	CbGeAlD
Levothyroxine—Diarrhoea—Chlorambucil—testicular cancer	0.000443	0.00399	CcSEcCtD
Levothyroxine—Flushing—Etoposide—testicular cancer	0.000442	0.00398	CcSEcCtD
Levothyroxine—Confusional state—Ifosfamide—testicular cancer	0.000432	0.00389	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000426	0.00384	CcSEcCtD
Levothyroxine—Asthenia—Vinblastine—testicular cancer	0.000426	0.00384	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Epirubicin—testicular cancer	0.000425	0.00384	CcSEcCtD
Levothyroxine—Tremor—Cisplatin—testicular cancer	0.000424	0.00382	CcSEcCtD
Levothyroxine—Alopecia—Etoposide—testicular cancer	0.000421	0.00379	CcSEcCtD
Levothyroxine—Hyperhidrosis—Ifosfamide—testicular cancer	0.000414	0.00373	CcSEcCtD
Levothyroxine—Feeling abnormal—Bleomycin—testicular cancer	0.000413	0.00372	CcSEcCtD
Levothyroxine—Vomiting—Chlorambucil—testicular cancer	0.000412	0.00371	CcSEcCtD
Levothyroxine—Increased appetite—Epirubicin—testicular cancer	0.000411	0.0037	CcSEcCtD
Levothyroxine—Diarrhoea—Vinblastine—testicular cancer	0.000406	0.00366	CcSEcCtD
Levothyroxine—Fatigue—Dactinomycin—testicular cancer	0.000403	0.00363	CcSEcCtD
Levothyroxine—Urticaria—Bleomycin—testicular cancer	0.000398	0.00359	CcSEcCtD
Levothyroxine—Body temperature increased—Bleomycin—testicular cancer	0.000396	0.00357	CcSEcCtD
Levothyroxine—Hypoglycaemia—Epirubicin—testicular cancer	0.000395	0.00356	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—testicular cancer	0.000395	0.00356	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000394	0.00355	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—testicular cancer	0.000393	0.00355	CcSEcCtD
Levothyroxine—Convulsion—Cisplatin—testicular cancer	0.000392	0.00353	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—testicular cancer	0.00039	0.00352	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00039	0.00352	CcSEcCtD
Levothyroxine—Feeling abnormal—Dactinomycin—testicular cancer	0.000385	0.00347	CcSEcCtD
Levothyroxine—Nausea—Chlorambucil—testicular cancer	0.000385	0.00347	CcSEcCtD
Levothyroxine—Anxiety—Cisplatin—testicular cancer	0.000384	0.00346	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000382	0.00345	CcSEcCtD
Levothyroxine—Dyspnoea—Ifosfamide—testicular cancer	0.000382	0.00344	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—testicular cancer	0.00038	0.00343	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—testicular cancer	0.00038	0.00342	CcSEcCtD
Levothyroxine—Vomiting—Vinblastine—testicular cancer	0.000377	0.0034	CcSEcCtD
Levothyroxine—Headache—Vinblastine—testicular cancer	0.000372	0.00335	CcSEcCtD
Levothyroxine—Body temperature increased—Dactinomycin—testicular cancer	0.000369	0.00333	CcSEcCtD
Levothyroxine—Abdominal pain—Dactinomycin—testicular cancer	0.000369	0.00333	CcSEcCtD
Levothyroxine—Fatigue—Ifosfamide—testicular cancer	0.000369	0.00333	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—testicular cancer	0.000367	0.00331	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—testicular cancer	0.000366	0.0033	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—testicular cancer	0.000366	0.0033	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—testicular cancer	0.000365	0.0033	CcSEcCtD
Levothyroxine—ABCB1—female gonad—testicular cancer	0.000362	0.00672	CbGeAlD
Levothyroxine—Tachycardia—Cisplatin—testicular cancer	0.00036	0.00325	CcSEcCtD
Levothyroxine—Asthenia—Bleomycin—testicular cancer	0.00036	0.00324	CcSEcCtD
Levothyroxine—Convulsion—Etoposide—testicular cancer	0.000359	0.00324	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—testicular cancer	0.000359	0.00323	CcSEcCtD
Levothyroxine—Hyperhidrosis—Cisplatin—testicular cancer	0.000357	0.00322	CcSEcCtD
Levothyroxine—Pruritus—Bleomycin—testicular cancer	0.000355	0.0032	CcSEcCtD
Levothyroxine—Feeling abnormal—Ifosfamide—testicular cancer	0.000353	0.00318	CcSEcCtD
Levothyroxine—Nausea—Vinblastine—testicular cancer	0.000352	0.00318	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—testicular cancer	0.000351	0.00317	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00035	0.00316	CcSEcCtD
Levothyroxine—Confusional state—Etoposide—testicular cancer	0.000341	0.00308	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—testicular cancer	0.00034	0.00307	CcSEcCtD
Levothyroxine—Urticaria—Ifosfamide—testicular cancer	0.00034	0.00307	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—testicular cancer	0.000339	0.00306	CcSEcCtD
Levothyroxine—Abdominal pain—Ifosfamide—testicular cancer	0.000339	0.00305	CcSEcCtD
Levothyroxine—Body temperature increased—Ifosfamide—testicular cancer	0.000339	0.00305	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—testicular cancer	0.000338	0.00305	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000336	0.00303	CcSEcCtD
Levothyroxine—Asthenia—Dactinomycin—testicular cancer	0.000335	0.00302	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—testicular cancer	0.000333	0.00301	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—testicular cancer	0.000332	0.00299	CcSEcCtD
Levothyroxine—Tachycardia—Etoposide—testicular cancer	0.00033	0.00298	CcSEcCtD
Levothyroxine—Dyspnoea—Cisplatin—testicular cancer	0.000329	0.00297	CcSEcCtD
Levothyroxine—Hyperhidrosis—Etoposide—testicular cancer	0.000327	0.00295	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—testicular cancer	0.000325	0.00293	CcSEcCtD
Levothyroxine—ABCB1—testis—testicular cancer	0.000321	0.00596	CbGeAlD
Levothyroxine—Diarrhoea—Dactinomycin—testicular cancer	0.00032	0.00288	CcSEcCtD
Levothyroxine—Vomiting—Bleomycin—testicular cancer	0.000319	0.00287	CcSEcCtD
Levothyroxine—Rash—Bleomycin—testicular cancer	0.000316	0.00285	CcSEcCtD
Levothyroxine—Dermatitis—Bleomycin—testicular cancer	0.000316	0.00285	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—testicular cancer	0.000315	0.00284	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—testicular cancer	0.000308	0.00278	CcSEcCtD
Levothyroxine—Asthenia—Ifosfamide—testicular cancer	0.000307	0.00277	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—testicular cancer	0.000305	0.00275	CcSEcCtD
Levothyroxine—Feeling abnormal—Cisplatin—testicular cancer	0.000304	0.00274	CcSEcCtD
Levothyroxine—Pruritus—Ifosfamide—testicular cancer	0.000303	0.00273	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—testicular cancer	0.000302	0.00272	CcSEcCtD
Levothyroxine—Dyspnoea—Etoposide—testicular cancer	0.000302	0.00272	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—testicular cancer	0.000301	0.00271	CcSEcCtD
Levothyroxine—Nausea—Bleomycin—testicular cancer	0.000298	0.00268	CcSEcCtD
Levothyroxine—Vomiting—Dactinomycin—testicular cancer	0.000297	0.00268	CcSEcCtD
Levothyroxine—Rash—Dactinomycin—testicular cancer	0.000295	0.00266	CcSEcCtD
Levothyroxine—Diarrhoea—Ifosfamide—testicular cancer	0.000293	0.00264	CcSEcCtD
Levothyroxine—Body temperature increased—Cisplatin—testicular cancer	0.000292	0.00263	CcSEcCtD
Levothyroxine—Fatigue—Etoposide—testicular cancer	0.000292	0.00263	CcSEcCtD
Levothyroxine—Sweating—Epirubicin—testicular cancer	0.000285	0.00257	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—testicular cancer	0.000279	0.00252	CcSEcCtD
Levothyroxine—Feeling abnormal—Etoposide—testicular cancer	0.000279	0.00251	CcSEcCtD
Levothyroxine—Nausea—Dactinomycin—testicular cancer	0.000278	0.0025	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Etoposide—testicular cancer	0.000277	0.00249	CcSEcCtD
Levothyroxine—Vomiting—Ifosfamide—testicular cancer	0.000272	0.00246	CcSEcCtD
Levothyroxine—Rash—Ifosfamide—testicular cancer	0.00027	0.00243	CcSEcCtD
Levothyroxine—Dermatitis—Ifosfamide—testicular cancer	0.00027	0.00243	CcSEcCtD
Levothyroxine—Urticaria—Etoposide—testicular cancer	0.000269	0.00242	CcSEcCtD
Levothyroxine—Abdominal pain—Etoposide—testicular cancer	0.000267	0.00241	CcSEcCtD
Levothyroxine—Body temperature increased—Etoposide—testicular cancer	0.000267	0.00241	CcSEcCtD
Levothyroxine—Asthenia—Cisplatin—testicular cancer	0.000265	0.00239	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—testicular cancer	0.000264	0.00238	CcSEcCtD
Levothyroxine—Nausea—Ifosfamide—testicular cancer	0.000254	0.00229	CcSEcCtD
Levothyroxine—Diarrhoea—Cisplatin—testicular cancer	0.000253	0.00228	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—testicular cancer	0.000252	0.00227	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—testicular cancer	0.000248	0.00223	CcSEcCtD
Levothyroxine—Asthenia—Etoposide—testicular cancer	0.000243	0.00219	CcSEcCtD
Levothyroxine—Pruritus—Etoposide—testicular cancer	0.000239	0.00216	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—testicular cancer	0.000238	0.00215	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—testicular cancer	0.000236	0.00213	CcSEcCtD
Levothyroxine—Vomiting—Cisplatin—testicular cancer	0.000235	0.00212	CcSEcCtD
Levothyroxine—ABCB1—lymph node—testicular cancer	0.000233	0.00432	CbGeAlD
Levothyroxine—Rash—Cisplatin—testicular cancer	0.000233	0.0021	CcSEcCtD
Levothyroxine—Dermatitis—Cisplatin—testicular cancer	0.000233	0.0021	CcSEcCtD
Levothyroxine—Diarrhoea—Etoposide—testicular cancer	0.000231	0.00209	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—testicular cancer	0.000229	0.00207	CcSEcCtD
Levothyroxine—Tension—Epirubicin—testicular cancer	0.000228	0.00206	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—testicular cancer	0.000226	0.00203	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—testicular cancer	0.000221	0.00199	CcSEcCtD
Levothyroxine—Nausea—Cisplatin—testicular cancer	0.000219	0.00198	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—testicular cancer	0.000218	0.00197	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—testicular cancer	0.000215	0.00194	CcSEcCtD
Levothyroxine—Vomiting—Etoposide—testicular cancer	0.000215	0.00194	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—testicular cancer	0.000213	0.00192	CcSEcCtD
Levothyroxine—Rash—Etoposide—testicular cancer	0.000213	0.00192	CcSEcCtD
Levothyroxine—Dermatitis—Etoposide—testicular cancer	0.000213	0.00192	CcSEcCtD
Levothyroxine—Headache—Etoposide—testicular cancer	0.000212	0.00191	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—testicular cancer	0.000211	0.00191	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—testicular cancer	0.000211	0.0019	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—testicular cancer	0.000209	0.00188	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—testicular cancer	0.000205	0.00185	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—testicular cancer	0.000204	0.00184	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—testicular cancer	0.000201	0.00181	CcSEcCtD
Levothyroxine—Nausea—Etoposide—testicular cancer	0.000201	0.00181	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—testicular cancer	0.000198	0.00178	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—testicular cancer	0.000198	0.00178	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—testicular cancer	0.000197	0.00178	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—testicular cancer	0.000196	0.00177	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—testicular cancer	0.000191	0.00172	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—testicular cancer	0.00019	0.00171	CcSEcCtD
Levothyroxine—Shock—Epirubicin—testicular cancer	0.000187	0.00168	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—testicular cancer	0.000186	0.00168	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—testicular cancer	0.000185	0.00167	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000185	0.00166	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—testicular cancer	0.000183	0.00165	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—testicular cancer	0.000183	0.00165	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—testicular cancer	0.000183	0.00165	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—testicular cancer	0.000182	0.00164	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—testicular cancer	0.000181	0.00163	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—testicular cancer	0.000177	0.00159	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—testicular cancer	0.000175	0.00157	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000173	0.00156	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—testicular cancer	0.000173	0.00156	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—testicular cancer	0.000171	0.00155	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—testicular cancer	0.000171	0.00154	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00017	0.00153	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—testicular cancer	0.000169	0.00152	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—testicular cancer	0.000167	0.00151	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000166	0.00149	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—testicular cancer	0.000163	0.00147	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—testicular cancer	0.000161	0.00145	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—testicular cancer	0.00016	0.00144	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—testicular cancer	0.00016	0.00144	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00016	0.00144	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—testicular cancer	0.000159	0.00143	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—testicular cancer	0.000156	0.00141	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—testicular cancer	0.000156	0.00141	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000155	0.0014	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—testicular cancer	0.000151	0.00136	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—testicular cancer	0.000151	0.00136	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—testicular cancer	0.00015	0.00135	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—testicular cancer	0.00015	0.00135	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—testicular cancer	0.000145	0.00131	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—testicular cancer	0.000145	0.0013	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000143	0.00129	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—testicular cancer	0.000143	0.00129	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—testicular cancer	0.000139	0.00126	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—testicular cancer	0.000139	0.00125	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—testicular cancer	0.000139	0.00125	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—testicular cancer	0.000139	0.00125	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—testicular cancer	0.000136	0.00123	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—testicular cancer	0.000134	0.00121	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—testicular cancer	0.00013	0.00117	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—testicular cancer	0.000129	0.00116	CcSEcCtD
Levothyroxine—Rash—Methotrexate—testicular cancer	0.000128	0.00115	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—testicular cancer	0.000128	0.00115	CcSEcCtD
Levothyroxine—Headache—Methotrexate—testicular cancer	0.000127	0.00114	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—testicular cancer	0.000126	0.00113	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—testicular cancer	0.000124	0.00112	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—testicular cancer	0.000121	0.00109	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—testicular cancer	0.00012	0.00109	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—testicular cancer	0.00012	0.00108	CcSEcCtD
Levothyroxine—Rash—Epirubicin—testicular cancer	0.00012	0.00108	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—testicular cancer	0.000119	0.00108	CcSEcCtD
Levothyroxine—Headache—Epirubicin—testicular cancer	0.000119	0.00107	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—testicular cancer	0.000113	0.00102	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—testicular cancer	0.000112	0.00101	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—testicular cancer	0.000111	0.000997	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—testicular cancer	0.000111	0.000996	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—testicular cancer	0.00011	0.000991	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—testicular cancer	0.000104	0.00094	CcSEcCtD
